Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ORLANDO PORTAL

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1366626111
CMS profile
1170705
Location
RIVERVIEW, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$326.18

20 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $326.18 20

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ORLANDO PORTAL

NPI 1366626111 · CMS profile ID 1170705

Allopathic & Osteopathic Physicians / Internal Medicine

RIVERVIEW, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1366626111?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ORLANDO PORTAL, NPI 1366626111, CMS profile ID 1170705. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1366626111?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ORLANDO PORTAL, NPI 1366626111, CMS profile ID 1170705. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1366626111?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ORLANDO PORTAL, NPI 1366626111, CMS profile ID 1170705, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1366626111?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

20 matching records · $326.18 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 20 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–20 of 20.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $18.5912/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050203953 CMS
PFIZER INC. $16.8512/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049641513 CMS
ABBVIE INC. $17.6812/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998154731 CMS
Teva Pharmaceuticals USA, Inc. $13.8511/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056910007 CMS
PFIZER INC. $4.9810/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050168995 CMS
Teva Pharmaceuticals USA, Inc. $19.8110/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056909945 CMS
Neurocrine Biosciences, Inc. $18.8809/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052351873 CMS
Astellas Pharma US Inc $21.0309/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034503293 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.0609/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057430839 CMS
PFIZER INC. $5.2008/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049930581 CMS
PFIZER INC. $11.6507/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050056223 CMS
PFIZER INC. $28.7107/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050318215 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.5706/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057408443 CMS
ABBVIE INC. $14.9305/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998154729 CMS
Astellas Pharma US Inc $17.1604/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034078261 CMS
PFIZER INC. $1.4504/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049518889 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.7904/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057401165 CMS
Hikma Pharmaceuticals USA $15.4704/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053748909 CMS
ABBVIE INC. $15.1803/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998154727 CMS
PFIZER INC. $24.3402/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049581921 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $339.77 20
PY2020 $298.44 13
PY2021 $266.84 14
PY2022 $319.46 11
PY2023 $326.18 20
PY2024 $297.63 17
PY2025 $444.62 21

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $36,684.90 12
PY2024 Principal investigator $133,245.43 14
PY2023 Recipient $234,416.46 5
PY2023 Principal investigator $136,269.05 9
PY2022 Principal investigator $466,568.40 55
PY2021 Principal investigator $384,286.25 64
PY2020 Principal investigator $42,422.64 15

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $20,487.67 12/05/2024 Non-covered Recipient Entity
JSV Clinical Research Study Inc
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1130953117
Principal investigator 1 PFIZER INC. $4,075.00 10/17/2024 Non-covered Recipient Entity
JSV Clinical Research Study Inc
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1130974424
Principal investigator 1 PFIZER INC. $4,650.00 09/26/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131019068
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $2,500.00 04/17/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF AVP-786 (DEUTERATED [D6]-DEXTROMETHORPHAN HYDROBROMIDE [D6-DM]/QUINIDINE SULFATE [Q]) FOR THE TREATMENT OF AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMERS TYPE No dispute reported 06/30/2026 1118845736
Principal investigator 1 PFIZER INC. $1,875.00 03/27/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131051248
Principal investigator 1 PFIZER INC. $1,000.00 03/21/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131051197
Principal investigator 1 PFIZER INC. $495.00 03/21/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131054936
Principal investigator 1 PFIZER INC. $2,633.40 03/21/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131061762
Principal investigator 1 PFIZER INC. $574.20 03/21/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131061803
Principal investigator 1 PFIZER INC. $9,828.00 03/21/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131062668
Principal investigator 1 PFIZER INC. $3,000.00 03/21/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131062674
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $61,811.84 03/19/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF AVP-786 (DEUDEXTROMETHORPHAN HYDROBROMIDE [D6 DM]/QUINIDINE SULFATE [Q]) FOR THE TREATMENT OF AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMERS TYPE No dispute reported 06/30/2026 1118845552
Principal investigator 1 PFIZER INC. $6,176.40 02/15/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131060087
Principal investigator 1 PFIZER INC. $14,138.92 01/18/2024 Non-covered Recipient Entity
JSV CLINICAL RESEARCH STUDY INC
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1131049274